Compare ALLY & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLY | CRL |
|---|---|---|
| Founded | 1919 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 10.9B |
| IPO Year | 2011 | 1999 |
| Metric | ALLY | CRL |
|---|---|---|
| Price | $45.75 | $233.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $54.42 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 2.8M | 809.6K |
| Earning Date | 04-17-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 31.67 | N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $7,914,000,000.00 | $1,857,601,000.00 |
| Revenue This Year | $24.30 | N/A |
| Revenue Next Year | $4.31 | $3.04 |
| P/E Ratio | $48.49 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $35.92 | $144.26 |
| 52 Week High | $47.29 | $236.62 |
| Indicator | ALLY | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 54.74 | 73.63 |
| Support Level | $44.90 | $161.39 |
| Resistance Level | $46.97 | N/A |
| Average True Range (ATR) | 1.10 | 8.65 |
| MACD | -0.18 | 1.51 |
| Stochastic Oscillator | 56.06 | 92.31 |
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.